This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hill-Rom Holdings Management Presents At Credit Suisse Group Healthcare Conference - Conference Call Transcript

Certainly there are rising acuities across the Care Continuum. We, you know, see those as positive demographics for our business, ageing population, complex co-morbidities and obesity. And then, again, you know, we’re addressing those through daily driven clinical evidence and increasing R&D investment as we talked about at our Investor Day, and I’ll touch on that a little more in a minute. We’re looking to increase our level of R&D investment, combination of new products to meet some of these needs and also developing even more clinical evidence to support our value proposition.

Certainly, a care giver safety as a major issue and you know, that – its impact on satisfaction and turnover. We have products that improve our genomics. And certainly, can support reduction in injuries, especially back injuries etcetera through some of our aims to mobility. And both our lists and our frame businesses both help support that area.

Emerging populations, requiring increased access to care. You know, certainly we are focused not just in the developed world, North America, Western Europe, but we recognize the opportunities and the needs to develop region specific products and that are certainly things that we’re working on within our R&D investments as well.

And then, increased movement of healthcare outside the Acute Setting and into the Post-Acute Setting, be it in the extended care or home care, is certainly a trend that we see and one that we’re looking to meet. We do have product offering that’s been in the Care Continuum today. And we’re certainly looking to strengthen that position.

Read the rest of this transcript for free on seekingalpha.com

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs